- Home
- RCM vs HALO Comparison
RCM vs HALO Comparison
Compare RCM & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCM
- HALO
- Stock Information
- Founded
- RCM 2003
- HALO 1998
- Country
- RCM United States
- HALO United States
- Employees
- RCM N/A
- HALO N/A
- Industry
- RCM Other Consumer Services
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RCM Consumer Discretionary
- HALO Health Care
- Exchange
- RCM Nasdaq
- HALO Nasdaq
- Market Cap
- RCM 6.0B
- HALO 6.4B
- IPO Year
- RCM 2010
- HALO N/A
- Fundamental
- Price
- RCM $14.30
- HALO $45.65
- Analyst Decision
- RCM Buy
- HALO Buy
- Analyst Count
- RCM 15
- HALO 9
- Target Price
- RCM $15.30
- HALO $61.11
- AVG Volume (30 Days)
- RCM 2.7M
- HALO 1.7M
- Earning Date
- RCM 11-05-2024
- HALO 10-31-2024
- Dividend Yield
- RCM N/A
- HALO N/A
- EPS Growth
- RCM N/A
- HALO 61.71
- EPS
- RCM N/A
- HALO 3.02
- Revenue
- RCM $2,463,700,000.00
- HALO $947,355,000.00
- Revenue This Year
- RCM $14.10
- HALO $23.36
- Revenue Next Year
- RCM $14.39
- HALO $15.15
- P/E Ratio
- RCM N/A
- HALO $15.10
- Revenue Growth
- RCM 11.36
- HALO 21.35
- 52 Week Low
- RCM $8.87
- HALO $33.15
- 52 Week High
- RCM $15.12
- HALO $65.53
- Technical
- Relative Strength Index (RSI)
- RCM 72.28
- HALO 30.20
- Support Level
- RCM $14.14
- HALO $50.01
- Resistance Level
- RCM $14.30
- HALO $62.13
- Average True Range (ATR)
- RCM 0.02
- HALO 2.60
- MACD
- RCM -0.00
- HALO -0.50
- Stochastic Oscillator
- RCM 85.71
- HALO 0.15
About RCM R1 RCM Inc.
R1 RCM Inc is a provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers. Its services help healthcare providers generate sustainable improvements in their operating margins and cash flows while also enhancing patient, physician, and staff satisfaction for the customers, Its service offering consists of end-to-end RCM services for health systems, hospitals, and physician groups that provide comprehensive revenue cycle infrastructure to providers, including all revenue cycle personnel, technology solutions, and process workflow. The majority of the revenue comes from the operating fees received.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.